Clinical Studies & Research
KX-826 for Skin Phase II Enrollment Completed: ...
Why KX-826 Matters for Acne Care Acne often stems from hormonal imbalances, specifically androgens like DHT that trigger sebum overproduction and clogged pores. KX-826 (pyrilutamide) is a new, topical anti-androgen...
KX-826 for Skin Phase II Enrollment Completed: ...
Why KX-826 Matters for Acne Care Acne often stems from hormonal imbalances, specifically androgens like DHT that trigger sebum overproduction and clogged pores. KX-826 (pyrilutamide) is a new, topical anti-androgen...
KX-826 Completes Phase III Trial in Men: What I...
Introduction Another major milestone has been reached in the development of KX-826 (Pyrilutamide), the breakthrough topical treatment for pattern hair loss. Kintor Pharmaceuticals has officially completed its Phase III clinical...
KX-826 Completes Phase III Trial in Men: What I...
Introduction Another major milestone has been reached in the development of KX-826 (Pyrilutamide), the breakthrough topical treatment for pattern hair loss. Kintor Pharmaceuticals has officially completed its Phase III clinical...
KX-826 Cleared for U.S. Clinical Trials: Why It...
Introduction In a major step forward for hair loss treatment innovation, Kintor Pharmaceuticals has received IND (Investigational New Drug) clearance from the U.S. FDA for KX-826 (Pyrilutamide), paving the way...
KX-826 Cleared for U.S. Clinical Trials: Why It...
Introduction In a major step forward for hair loss treatment innovation, Kintor Pharmaceuticals has received IND (Investigational New Drug) clearance from the U.S. FDA for KX-826 (Pyrilutamide), paving the way...
KX-826 Shows Promising Results in Women with Pa...
Introduction Kintor Pharmaceuticals has announced topline results from its Phase II clinical trial of KX-826 in women with androgenetic alopecia (AGA), also known as female pattern hair loss. These early...
KX-826 Shows Promising Results in Women with Pa...
Introduction Kintor Pharmaceuticals has announced topline results from its Phase II clinical trial of KX-826 in women with androgenetic alopecia (AGA), also known as female pattern hair loss. These early...